Department of Inspection, The medical faculty of Qingdao University, Qingdao, 266003, China.
School of Public Health, Qingdao University, Qingdao, 266003, China.
Mol Cancer. 2019 Aug 9;18(1):123. doi: 10.1186/s12943-019-1052-9.
Piwi interacting RNAs (piRNAs) constitute novel small non-coding RNA molecules of approximately 24-31 nucleotides in length that often bind to members of the piwi protein family to play regulatory roles. Recently, emerging evidence suggests that in addition to the mammalian germline, piRNAs are also expressed in a tissue-specific manner in a variety of human tissues and modulate key signaling pathways at the transcriptional or post-transcriptional level. In addition, a growing number of studies have shown that piRNA and PIWI proteins, which are abnormally expressed in various cancers, may serve as novel biomarkers and therapeutic targets for tumor diagnostics and treatment. However, the functions of piRNAs in cancer and their underlying mechanisms remain incompletely understood. In this review, we discuss current findings regarding piRNA biogenetic processes, functions, and emerging roles in cancer, providing new insights regarding the potential applications of piRNAs and piwi proteins in cancer diagnosis and clinical treatment.
Piwi 相互作用 RNA(piRNAs)是一种新型的大约 24-31 个核苷酸长的小非编码 RNA 分子,通常与 piwi 蛋白家族成员结合发挥调节作用。最近,新出现的证据表明,piRNAs 除了在哺乳动物生殖系中表达外,还以组织特异性的方式在各种人类组织中表达,并在转录或转录后水平上调节关键的信号通路。此外,越来越多的研究表明,在各种癌症中异常表达的 piRNA 和 PIWI 蛋白可能作为肿瘤诊断和治疗的新型生物标志物和治疗靶点。然而,piRNAs 在癌症中的功能及其潜在机制仍不完全清楚。在这篇综述中,我们讨论了 piRNA 生物发生过程、功能以及在癌症中的新兴作用的最新发现,为 piRNAs 和 piwi 蛋白在癌症诊断和临床治疗中的潜在应用提供了新的见解。